5 Most Important Psychedelic Clinical Trials in 2022
James Halifax, Psychedelic Spotlight writer and their resident psychedelic investor, recently covered his 5 most…
DMT-Assisted Therapy May Address Root Cause of Major Depression
Gail Dutton of BioSpace.com, a leading online biotechnology source for breaking industry news and expert analysis,…
Small Pharma CEO Peter Rand & CMSO Dr Carol Routledge at the 34th Annual Roth Conference
View Small Pharma’s Fireside Chat Webcast from the 34th Annual Roth Conference Monday, March 14 at 3:30…
The Latest in DMT Research: Leading Companies and Key Studies
Truffle Report put together this roundup of the top corporate and scientific developments involving the…
What is DMT therapy?
By Dr Carol Routledge, Chief Medical & Scientific Officer, as originally featured in Drug Science DMT-assisted…
DMT-assisted therapy: changing the way we think about depressive disorders
Our CMSO Carol Routledge spoke to Bioscience Today about the world-leading psychedelic therapy research happening…
The Psychedelic Investor asks: Can DMT Treat Depression?
Can DMT treat depression? James Hallifax, of the Psychedelic Spotlight podcast, sits down to interview…
The Dales Report lists Small Pharma as one of 10 Psychedelic Companies To Watch In 2022
Small Pharma (CVE: DMT) (OTCMKTS: DMTTF) are delighted to be highlighted as one of the…
DMT: A Trip To Get Away From Depression?
Ruairi Mackenzie, Senior Science Writer for Technology Networks, recently interviewed Peter Rands, Small Pharma CEO,…
The Sifted Podcast Episode Two: The Companies Going Psychedelic
In this episode, you’ll hear from Dr Carol Routledge, Chief Medical and Scientific Officer at…